2014ESC/EACTS心肌血管重建术指南

Myocardial revascularization has been subject to more randomizednclinical trials (RCTs) than almost any other intervention. In order to inform the current Guidelines, this Task Force performed a systematic review of all RCTs performed since 1980, comparing head-to-head the different revascularization strategies—including CABG, balloon angioplasty, and PCI with bare-metal stents (BMS) or with various US Food and Drug Administration-approved drug-eluting stents (DES)—against medical treatment as well as different revascularization strategies, and retrieved 100 RCTs involving 93,553 patients with 262,090 patient-years of follow-up.